Entity Details

Primary name TCPR2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO15040
EntryNameTCPR2_HUMAN
FullNameTectonin beta-propeller repeat-containing protein 2
TaxID9606
Evidenceevidence at protein level
Length1411
SequenceStatuscomplete
DateCreated2001-02-21
DateModified2021-06-02

Ontological Relatives

GenesTECPR2

GO terms

Show/Hide Table
GOName
GO:0005737 cytoplasm
GO:0006914 autophagy
GO:0032527 protein exit from endoplasmic reticulum

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR001680 WD40 repeatRepeatRepeat
IPR006624 Beta-propeller repeat TECPRRepeatRepeat
IPR009091 Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein IIFamilyHomologous superfamily
IPR015943 WD40/YVTN repeat-like-containing domain superfamilyFamilyHomologous superfamily
IPR029772 Tectonin beta-propeller repeat-containing protein 2FamilyFamily
IPR036322 WD40-repeat-containing domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615031 OMIMSpastic paraplegia 49, autosomal recessive (SPG49)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations. SPG49 is characterized by delayed psychomotor development, mental retardation, and onset of spastic paraplegia in the first decade. Affected individuals also have dysmorphic features, thin corpus callosum on brain imaging, and episodes of central apnea, which may be fatal. The disease is caused by variants affecting the gene represented in this entry.